ELAB
Price
$2.25
Change
-$0.02 (-0.88%)
Updated
Jul 29, 01:31 PM (EDT)
Capitalization
3.12M
MTNB
Price
$0.88
Change
-$0.05 (-5.38%)
Updated
Jul 29, 02:59 PM (EDT)
Capitalization
4.73M
Interact to see
Advertisement

ELAB vs MTNB

Header iconELAB vs MTNB Comparison
Open Charts ELAB vs MTNBBanner chart's image
PMGC Holdings
Price$2.25
Change-$0.02 (-0.88%)
Volume$200
Capitalization3.12M
Matinas Biopharma Holdings
Price$0.88
Change-$0.05 (-5.38%)
Volume$375
Capitalization4.73M
ELAB vs MTNB Comparison Chart in %
Loading...
ELAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MTNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ELAB vs. MTNB commentary
Jul 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELAB is a Buy and MTNB is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 29, 2025
Stock price -- (ELAB: $2.27 vs. MTNB: $0.93)
Brand notoriety: ELAB and MTNB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ELAB: 2% vs. MTNB: 9%
Market capitalization -- ELAB: $3.12M vs. MTNB: $4.73M
ELAB [@Biotechnology] is valued at $3.12M. MTNB’s [@Biotechnology] market capitalization is $4.73M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELAB’s FA Score shows that 1 FA rating(s) are green whileMTNB’s FA Score has 1 green FA rating(s).

  • ELAB’s FA Score: 1 green, 4 red.
  • MTNB’s FA Score: 1 green, 4 red.
According to our system of comparison, both ELAB and MTNB are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELAB’s TA Score shows that 4 TA indicator(s) are bullish while MTNB’s TA Score has 3 bullish TA indicator(s).

  • ELAB’s TA Score: 4 bullish, 4 bearish.
  • MTNB’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ELAB is a better buy in the short-term than MTNB.

Price Growth

ELAB (@Biotechnology) experienced а -5.02% price change this week, while MTNB (@Biotechnology) price change was -3.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.88%. For the same industry, the average monthly price growth was +20.23%, and the average quarterly price growth was +47.54%.

Industries' Descriptions

@Biotechnology (+6.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MTNB($4.73M) has a higher market cap than ELAB($3.12M). MTNB YTD gains are higher at: 82.353 vs. ELAB (-85.839). ELAB has higher annual earnings (EBITDA): -4.33M vs. MTNB (-15.35M). MTNB has more cash in the bank: 6.92M vs. ELAB (5.92M). ELAB has less debt than MTNB: ELAB (103K) vs MTNB (2.71M). ELAB (0) and MTNB (0) have equivalent revenues.
ELABMTNBELAB / MTNB
Capitalization3.12M4.73M66%
EBITDA-4.33M-15.35M28%
Gain YTD-85.83982.353-104%
P/E RatioN/AN/A-
Revenue00-
Total Cash5.92M6.92M86%
Total Debt103K2.71M4%
FUNDAMENTALS RATINGS
MTNB: Fundamental Ratings
MTNB
OUTLOOK RATING
1..100
69
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
51
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ELABMTNB
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
62%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 9 days ago
87%
Bullish Trend 20 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
ELAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MTNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APA19.570.47
+2.46%
APA Corp
WTO1.190.01
+0.85%
UTime Limited
TOWN35.700.09
+0.25%
TowneBank
FEAM4.11-0.11
-2.61%
5E Advanced Materials Inc.
HROW34.86-1.33
-3.68%
Harrow

ELAB and

Correlation & Price change

A.I.dvisor tells us that ELAB and EPIX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ELAB and EPIX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELAB
1D Price
Change %
ELAB100%
-0.44%
EPIX - ELAB
32%
Poorly correlated
-0.53%
LXRX - ELAB
21%
Poorly correlated
-0.91%
CLNN - ELAB
21%
Poorly correlated
-6.85%
ASMB - ELAB
20%
Poorly correlated
+5.12%
MTNB - ELAB
20%
Poorly correlated
-0.01%
More

MTNB and

Correlation & Price change

A.I.dvisor indicates that over the last year, MTNB has been closely correlated with TPST. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if MTNB jumps, then TPST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MTNB
1D Price
Change %
MTNB100%
-0.01%
TPST - MTNB
78%
Closely correlated
+4.12%
EQ - MTNB
38%
Loosely correlated
+10.65%
LIANY - MTNB
34%
Loosely correlated
+3.51%
INO - MTNB
31%
Poorly correlated
+0.68%
AKRO - MTNB
30%
Poorly correlated
-2.61%
More